http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20061288-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8f70c5b59b293a0220e30a752bb017f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 |
| filingDate | 2006-02-08^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d08f1812f4d495661d732722d284830 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42416ebc7391ebb0d306fdbd836616f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b55cd43db2bd969adbbf14fc8c5094 |
| publicationDate | 2006-11-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-20061288-A1 |
| titleOfInvention | N- [3- (8-SUBSTITUTED-IMIDAZO [1,5-a] PYRIMIDIN-4-IL) -PHENYL] -SULPHONAMIDES, N- [3- (8-SUBSTITUTED-IMIDAZO [1,5-a] PIRIMIDIN- 4-IL) -PHENYL] -CARBOXAMIDES, COMPOSITIONS AND RELATED METHODS |
| abstract | REFERS TO A COMPOUND OF FORMULA I, WHERE R1 IS C1-C6 ALKYL, C2-C6 ALKYL, C3-C6 CYCLOALKYL, AMONG OTHERS; R2 IS H, C1-C6 ALKYL, C2-C6 ALKENYL, AMONG OTHERS; R3 IS H, HALOGEN, C1-C6 ALKYL, AMONG OTHERS; X IS A CARBONYL OR SULFONYL GROUP. THE PREFERRED COMPOUNDS ARE: N- [3- [8- (THIOPHENE-2-CARBONYL) -IMIDAZO [1,5-a] PYRIMIDIN-4-IL] -PHENYL] -N-METHANOSULPHONAMIDE; N- [3- (8-CYANE-IMIDAZO [1,5-a] PYRIMIDIN-4-IL) -PHENYL] -N-PROP-2-INYL-ETHANOSULFONAMIDE; N- [3- [8- (4-FLUORO-BENZOYL) -IMIDAZO [1,5-a] PYRIMIDIN-4-IL] -PHENYL] -N-METHYLETHANOSULFONAMIDE; AMONG OTHERS. IT ALSO REFERS TO A PREPARATION PROCEDURE AND A PHARMACEUTICAL COMPOSITION. SUCH COMPOUNDS HAVE AFFINITY TO THE GABAA RECEPTOR AND IN SPECIFIC TO THE ALPHA1 AND ALPHA2 SUBUNITIES, BEING USEFUL IN THE TREATMENT OF INSOMNIA, ANXIETY, EPILEPSY, AMONG OTHERS |
| priorityDate | 2005-02-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427267 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID281 |
Showing number of triples: 1 to 21 of 21.